COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Abstract Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and transmissible coronavirus. Most cases of COVID‐19 have mild to moderate symptoms, including cough, fever, myalgias, and headache. On t...
Main Authors: | Ilker Polatoğlu, Tulay Oncu‐Oner, Irem Dalman, Senanur Ozdogan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.228 |
Similar Items
-
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
by: Vivek P. Chavda, et al.
Published: (2023-02-01) -
Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis
by: Eliana Specchiarello, et al.
Published: (2023-04-01) -
Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes
by: Alessio Lorusso, et al.
Published: (2021-03-01) -
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
by: Hanjun Zhao, et al.
Published: (2022-12-01) -
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
by: Nur Zawanah Zabidi, et al.
Published: (2023-04-01)